Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration

American Journal of Epidemiology

Volumn 161, Issue 11, 2005, Pages 1013-1019

  Robman, Luba ^a   Mahdi, Olaimatu ^b   McCarty, Catherine ^a,c   Dimitrov, Peter ^a   Tikellis, Gabriella ^a   McNeil, John ^d   Byrne, Gerald ^b   Taylor, Hugh ^a   Guymer, Robyn ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c MARSHFIELD CLINIC   (United States)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Chlamydophila pneumoniae; Disease progression; Infection; Macular degeneration

Indexed keywords

PNEUMONIA; SEXUALLY TRANSMITTED DISEASE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; PHOTOGRAPHY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; SMOKING;

AGED; AGED, 80 AND OVER; AGING; ANTIBODIES, BACTERIAL; CHLAMYDIACEAE INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RISK FACTORS;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 19544391460     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwi130     Document Type: Article

References (41)

1. Dimitrov P, Mukesh B, McCarty C, et al. Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment Project. Invest Ophthalmol Vis Sci 2003;44:5075-81.
2. Foran S, Wang JJ, Mitchell P. Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2003;10:215-25.
3. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-85.
4. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.
5. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205-10.
6. Mitchell P, Smith W, Attebo K, et al. Prevalence of age-related maculopathy in Australia. Ophthalmology 1995;102:1450-60.
7. Klein R, Klein B, Cruickshanks KJ. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999;18:371-89.
8. VanNewkirk M, Nanjan M, Wang J, et al. The prevalence of age-related maculopathy - the Visual Impairment Project. Ophthalmology 2000;107:1593-600.
9. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001;108:697-704.
10. Klein R. Epidemiology. In: Berger JW, Fine SL, Maguire MG, eds. Age-related macular degeneration. St Louis, MO: Mosby, Inc, 1999:31-55.
11. Fong IW. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 2000;163:49-56.
12. Shor A, Phillips JI. Chlamydia pneumoniae and atherosclerosis. JAMA 1999;282:2071-3.
13. Tutuncu NB, Guvener N, Tutuncu T, et al. Chlamydia pneumonia seropositivity correlates with serum fibrinogen and lipoprotein a levels: any role in atherosclerosis? Endocr J 2001;48:269-74.
14. Camm AJ, Fox KM. Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence? Eur Heart J 2000;21: 1046-51.
15. Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2002;2:11-17.
16. Gupta S. Chronic infection in the aetiology of atherosclerosis-focus on Chlamydia pneumoniae. Atherosclerosis 1999;143:1-6.
17. Taylor-Robinson D, Thomas BJ. Chlamydia pneumoniae in atherosclerotic tissue. J Infect Dis 2000;181(suppl 3): S437-40.
18. Sander D, Winbeck K, Klingelhofer J, et al. Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity. Circulation 2001;103:1390-5.
19. Kalayoglu M, Galvan C, Mahdi O, et al. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 2003;121: 478-82.
20. Ishida O, Oku H, Ikeda T, et al. Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration? Br J Ophthalmol 2003;87:523-4.
21. Kalayoglu MV, Bula D, Arroyo J, et al. Chlamydia pneumoniae is identified in human choroidal neovascular membranes secondary to age-related macular degeneration and induces vascular endothelial growth factor in vitro. (Abstract). Invest Ophthalmol Vis Sci 2004;45:3128.
22. Huhtinen M, Puolakkainen M, Laasila K, et al. Chlamydial antibodies in patients with previous acute anterior uveitis. Invest Ophthalmol Vis Sci 2001;42:1816-19.
23. Weger M, Haas A, Stanger O, et al. Chlamydia pneumoniae seropositivity and the risk of nonarteritic ischemic optic neuropathy. Ophthalmology 2002;109:749-52.
24. Robman L, Dimitrov P, Dowrick A, et al. Methodology of the CHARM Study: Cardiovascular Health and Age-Related Maculopathy. Ophthalmic Epidemiol 2004;11:161-79.
25. Livingston P, Carson C, Stanislavsky Y, et al. Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. Ophthalmic Epidemiol 1994;1:139-48.
26. Garrett SK, McNeil JJ, Silagy C, et al. Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy. Ophthalmic Epidemiol 1999;6:195-208.
27. Taylor HR, Tikellis G, Robman LD, et al. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ 2002;325:11-16.
28. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39: 367-74.
29. Tikellis G, Robman L, Harper C, et al. The VECAT study: methodology and statistical power for measurement of age-related macular features. Vitamin E, Cataract, and Age-related Maculopathy Study. Ophthalmic Epidemiol 1999;6:181-94.
30. Tikellis G, Robman LD, Harper A, et al. Methods for detecting age-related maculopathy: a comparison between photographic and clinical assessment. Clin Exp Ophthalmol 2000;28: 367-72.
31. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992;15:757-61.
32. Kuo CC, Jackson LA, Campbell LA, et al. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.
33. Verkooyen RP, Willemse D, Hier-van Casteren SC, et al. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Clin Microbiol 1998;36:2301-7.
34. Freidank HM, Brauer D. Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students. J Infect 1993;27:89-93.
35. Wang JH, Liu YC, Cheng DL, et al. Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand J Infect Dis 1993;25:565-8.
36. Ben-Yaakov M, Lazarovich Z, Beer S, et al. Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel. J Clin Pathol 1994;47:232-5.
37. Quinn T, Gaydos C. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Am Heart J 1999;138:S507-11.
38. Kvanta A, Algvere PV, Berglin L, et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular epithelial growth factor. Invest Ophthalmol Vis Sci 1996;37:1929-34.
39. Schwesinger C, Yee C, Rohan R. Intrastromal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 2001;158:1161-72.
40. Streblow DN, Orloff SL, Nelson JA. Do pathogens accelerate atherosclerosis? J Nutr 2001;131:2798S-804S.
41. Anderson JL, Muhlestein JB. Antibiotic trials for coronary heart disease. Tex Heart Inst J 2004;31:33-8.